Results 161 to 170 of about 25,277,741 (360)

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1980
Mevinolin, a fungal metabolite, was isolated from cultures of Aspergillus terreus. The structure and absolute configuration of mevinolini and its open acid form, mevinolinic acid, were determined by a combination of physical techniques.
A. Alberts   +19 more
semanticscholar   +1 more source

Metabolomic analysis reveals the molecular mechanism related to leg abnormality in broilers

open access: yesAnimal Research and One Health, EarlyView.
The graphical abstract shows the principal results of this study. Compared to the leg normal broilers, the serum calcium to phosphorus ratio was extremely decreased in the group with deformed leg bones. Additionally, a total of nine differential metabolites significantly associated with leg abnormalities and serum calcium and phosphorus levels were ...
Jumei Zheng   +9 more
wiley   +1 more source

Refinements of the inequalities between Neuman-Sandor, arithmetic, contra-harmonic and quadratic means [PDF]

open access: yesarXiv, 2012
In this paper, we prove that the inequalities $\alpha [1/3 Q(a,b)+2/3 A(a,b)]+(1-\alpha)Q^{1/3}(a,b)A^{2/3}(a,b)0$ with $
arxiv  

Linkage between coenzyme a metabolism and inflammation: roles of pantetheinase.

open access: yesJournal of Pharmacological Sciences, 2013
Pantetheinase is an enzyme hydrolyzing pantetheine, an intermediate of the coenzyme A degradation pathway. Pantetheinase has long been considered as the enzyme that recycles pantothenic acid (vitamin B5) generated during coenzyme A breakdown.
T. Nitto, K. Onodera
semanticscholar   +1 more source

Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials

open access: yesBMC Cardiovascular Disorders, 2017
Background The therapeutic efficacy of coenzyme Q10 on patients with cardiac failure remains controversial. We pooled previous clinical studies to re-evaluate the efficacy of coenzyme Q10 in patients with cardiac failure.
Li Lei, Yan Liu
doaj   +1 more source

Characterization of the pattern of development of key compounds contributing to aroma quality of chicken meat and their metabolic markers

open access: yesAnimal Research and One Health, EarlyView.
The graphical abstract shows the principal results of this study. Eight major aroma‐contributing compounds (nonanal, octanal, dimethyl tetrasulfide, hexanal, 1‐octen‐3‐ol, (E)‐2‐nonenal, heptanal, and (E,E)‐2,4‐decadienal) were identified by electronic nose and GC‐O‐MS analysis, and their content increased with age.
Yanke Wang   +6 more
wiley   +1 more source

Emergence of highly profibrotic and proinflammatory Lrat+Fbln2+ HSC subpopulation in alcoholic hepatitis

open access: yesHepatology, EarlyView., 2022
Lrat+ quiescent hepatic stellate cells (qHSC) give rise to Lrat+Fbln2+ activated HSC (aHSC) in alcohol‐associated hepatitis and this subpopulation is highly profibrotic, inflammatory, and immunoregulatory based on their single cell transcriptomic profile. Abstract Background and Aims Relative roles of HSCs and portal fibroblasts in alcoholic hepatitis (
Steven Balog   +12 more
wiley   +1 more source

Compact Subsets of the Glimm Space of a $C^*$-algebra [PDF]

open access: yesarXiv, 2012
If $A$ is a $\sigma$-unital $C^*$-algebra and $a$ is a strictly positive element of $A$ then for every compact subset $K$ of the complete regularization $\mathrm{Glimm}(A)$ of $\mathrm{Prim}(A)$ there exists $\alpha > 0$ such that $K\subset \{G\in \mathrm{Glimm}(A) \mid \|a + G\|\geq \alpha\}$. This extends a 1974 result of J.
arxiv  

Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial

open access: yesArthritis &Rheumatology, EarlyView.
Objective Our objective was to evaluate the efficacy and safety of subcutaneous (SC) abatacept and standard of care (SOC) for the treatment of idiopathic inflammatory myopathy (IIM) over 52 weeks. Methods In this randomized, double‐blind, placebo‐controlled phase III trial, patients with treatment‐refractory IIM received SC abatacept (at 125 mg weekly)
Rohit Aggarwal   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy